| Ms Jennifer Spalding Hagan, MS SLP | |
|
222 Hollywood Dr, Bardstown, KY 40004-1124 | |
| (502) 507-1052 | |
| Not Available |
| Full Name | Ms Jennifer Spalding Hagan |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 222 Hollywood Dr, Bardstown, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295935476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 140423 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jennifer Spalding Hagan, MS SLP 222 Hollywood Dr, Bardstown, KY 40004-1124 Ph: (502) 507-1052 | Ms Jennifer Spalding Hagan, MS SLP 222 Hollywood Dr, Bardstown, KY 40004-1124 Ph: (502) 507-1052 |
News Archive
Protalix BioTherapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease. Taliglucerase alfa is a plant-cell expressed form of glucocerebrosidase (GCD).
Speaker Nancy Pelosi today released the following statement on the benefits of the Affordable Care Act for America's seniors. President Obama held a tele-town hall with seniors in Wheaton, Md. today on the legislation's provisions to strengthen Medicare, close the 'donut hole,' and protect seniors from fraud.
Patients with diabetes, kidney disease and anemia who don't respond to treatment with an anti-anemia drug have a higher risk of cardiovascular disease or death, researchers at UT Southwestern Medical Center have found.
Star Scientific, Inc. announced that on Friday, June 18 the company filed an application with the Food & Drug Administration for approval to market Stonewall-BDL™ as a "modified risk tobacco product" under the Family Smoking Prevention and Tobacco Control Act of 2009. This is Star's second such application to the Tobacco Products Center of the FDA, which has been established to oversee all aspects of tobacco regulation outlined in the 2009 Act.
Scientists at Cold Spring Harbor Laboratory have identified a candidate drug target for treating acute myeloid leukemia, a white blood cell cancer that proliferates out of control in the bone marrow.
› Verified 1 days ago
Ms. Wynna Gail Cook, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Life Care Way, Bardstown, KY 40004 Phone: 502-348-4220 | |
Mr. Matthew Harris, Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 101 Isaac Greer Ct, Bardstown, KY 40004 Phone: 502-349-6214 | |
Trevor Wayne Dunn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Life Care Way, Bardstown, KY 40004 Phone: 502-348-4220 | |
Emily Hanna, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 S Salem Dr, Bardstown, KY 40004 Phone: 502-331-5478 | |
Sarah K Riggs, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 704 Bloomfield Rd, Bardstown, KY 40004 Phone: 502-331-5478 Fax: 502-348-9825 | |
Anna Reynolds Green, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5804 Loretto Rd, Bardstown, KY 40004 Phone: 502-827-3572 | |
Peggy A. Schlesinger, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 104 Welch Ln, Bardstown, KY 40004 Phone: 502-836-4414 |